Peroxisome proliferator-activated receptor γ (PPARG), when activated by ligands, can inhibit ventricular hypertrophy, improve ventricular remodeling, and enhance cardiac function (Miki et al., 2013). Here, PPARG is linked to cardiac hypertrophy.